EQUITY RESEARCH MEMO

Corscience

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Corscience is a German medical device development and consulting company founded in 2003, specializing in safety-critical cardiovascular technologies. As an independent partner, it offers end-to-end services including product development, regulatory affairs, quality management, and OEM technology modules. The company translates complex requirements into reliable system architectures and ensures compliance for market approval, serving clients in the medical device industry. With over two decades of experience, Corscience has established itself as a trusted partner for bringing innovative and compliant medical devices to market, particularly in the cardiovascular space.

Upcoming Catalysts (preview)

  • Q3 2026Expansion of Regulatory Consulting Services under EU MDR75% success
  • Q4 2026Launch of New OEM Technology Module for Cardiovascular Devices80% success
  • H1 2027Strategic Partnership with a Major Medtech Company50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)